Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...

Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...

Sen. Bernie Sanders grilled Novo Nordisk CEO Lars Jorgensen during a Tuesday Senate hearing regarding the cost of its weight-loss drugs in the U.S. In opening remarks before the Senate Health ...